Skip to main content
    R

    Rhythm Pharmaceuticals Inc (RYTM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $107.48
    -7.54 (-6.56%)

    Market Cap: $7.97B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Rhythm Pharmaceuticals Inc (RYTM) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Rhythm Pharmaceuticals are Krystal Biotech (KRYS), Mirum Pharmaceuticals (MIRM) and Madrigal Pharmaceuticals (MDGL). By market cap, Rhythm Pharmaceuticals ranks 8th of the 13 companies on this page; Jazz Pharmaceuticals (JAZZ) is the largest at $15.50B. The median P/E of the 4 companies with a P/E is 53.4x.

    Peer Comparison

    RYTM's ROIC of -98.6% is below the peer median of -6.3%, and its revenue growth of 79.6% is above the median of 44.9%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Rhythm Pharmaceuticals (RYTM)$7.97BN/A26.4x-69.0%-98.6%79.6%0.00%
    Krystal Biotech Inc (KRYS)$9.05B40.4x18.8x47.9%N/A30.2%0.00%
    Mirum Pharmaceuticals Inc (MIRM)$6.14BN/A8.9x-134.7%-133.6%39.6%0.00%
    Madrigal Pharmaceuticals Inc (MDGL)$9.93BN/A8.7x-10.9%-12.7%50.1%0.00%
    Cytokinetics Inc (CYTK)$7.82BN/A65.3x0.0%-66.0%2357.0%0.00%
    Scholar Rock Holding Corp (SRRK)$5.27BN/AN/A0.0%-89.0%-100.0%0.00%
    TG Therapeutics Inc (TGTX)$9.75B87.2x11.1x11.8%11.0%60.7%0.00%
    Praxis Precision Medicines Inc (PRAX)$9.17BN/AN/A0.0%N/A1349.0%0.00%
    Kymera Therapeutics Inc (KYMR)$10.89BN/A123.2x0.0%N/A466.4%0.00%
    PTC Therapeutics Inc (PTCT)$5.30BN/A5.2x-9.2%18.1%69.6%0.00%
    Jazz Pharmaceuticals PLC (JAZZ)$15.50B18.4x3.3x4.4%3.5%10.4%0.00%
    Apogee Therapeutics, Inc. Common Stock (APGE)$10.22BN/AN/A0.0%N/A0.0%0.00%
    Ligand Pharmaceuticals Incorporated (LGND)$6.18B66.5x23.7x20.3%0.1%-31.8%0.00%
    Peer median$9.11B53.4x11.1x0.0%-6.3%44.9%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Rhythm Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Krystal Biotech Inc (KRYS)
    Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United...
    KRYS competitors
    Mirum Pharmaceuticals Inc (MIRM)
    Mirum Pharmaceuticals, Inc., a biopharmaceutical company, is focused on the development and commercialization of an advanced line of novel therapies...
    MIRM competitors
    Madrigal Pharmaceuticals Inc (MDGL)
    Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates...
    MDGL competitors
    Cytokinetics Inc (CYTK)
    Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering...
    CYTK competitors
    Scholar Rock Holding Corp (SRRK)
    Scholar Rock Holding Corporation, a clinical-phase biopharmaceutical company, is focused on the discovery and development of drugs for the treatment of serious...
    SRRK competitors
    TG Therapeutics Inc (TGTX)
    TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development...
    TGTX competitors
    Praxis Precision Medicines Inc (PRAX)
    Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal...
    PRAX competitors
    Kymera Therapeutics Inc (KYMR)
    Kymera Therapeutics, Inc., a biopharmaceutical company, is focused on discovering and developing new small molecule treatments that selectively break down...
    KYMR competitors
    PTC Therapeutics Inc (PTCT)
    PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for patients with rare disorders.
    PTCT competitors
    Jazz Pharmaceuticals PLC (JAZZ)
    Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and markets pharmaceutical products for various unmet medical needs in the United...
    JAZZ competitors
    Apogee Therapeutics, Inc. Common Stock (APGE)
    Apogee Therapeutics, Inc., through its subsidiary, is a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD)...
    Ligand Pharmaceuticals Incorporated (LGND)
    Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies discover...
    LGND competitors

    Frequently Asked Questions About RYTM

    Who are Rhythm Pharmaceuticals' main competitors?

    The companies most similar to Rhythm Pharmaceuticals include Krystal Biotech (KRYS), Mirum Pharmaceuticals (MIRM), Madrigal Pharmaceuticals (MDGL), Cytokinetics (CYTK) and Scholar Rock Holding (SRRK), listed from the closest match.

    Who is Rhythm Pharmaceuticals' biggest competitor?

    Jazz Pharmaceuticals (JAZZ) is the largest of the similar companies at $15.50B; Krystal Biotech (KRYS) is the closest match by business profile, size, sector and industry.

    How does RYTM stock compare with its competitors?

    RYTM's P/S is 26.4x against a peer median of 11.1x; its net margin is -69.0% against a peer median of 0.0%.

    Which of Rhythm Pharmaceuticals' competitors pays a higher dividend?

    Rhythm Pharmaceuticals pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Rhythm Pharmaceuticals bigger than its competitors?

    No. Rhythm Pharmaceuticals is 8th by market cap among the 13 companies on this page; the largest is Jazz Pharmaceuticals (JAZZ) at $15.50B.